Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716-Reference-Cited by-同舟云学术

Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716

Published:2020-12 Issue: Volume:150 Page:145-151
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Danson Sarah J.,Conner Joe,Edwards John G.,Blyth Kevin G.,Fisher Patricia M.,Muthana Munitta,Salawu Abdulazeez,Taylor Fiona,Hodgkinson Elizabeth,Joyce Patrick,Roman Jennifer,Simpson Kathleen,Graham Alexander,Learmonth Kirsty,Woll Penella J.

Funder

Virttu/Sorrento and the ECMC Network

Weston Park Cancer Charity, Sheffield, UK

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. The Global Cancer observatory. Mesothelioma Report,2020

2. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J. Clin. Oncol.,2003

3. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion;Dresler;Chest,2005

4. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME-2 randomized control trial;Davies;JAMA,2012

5. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial;Thomas;JAMA,2017

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infusion and delivery strategies to maximize the efficacy of CAR-T cell immunotherapy for cancers;Experimental Hematology & Oncology;2024-07-26

2. Malignant Pleural Mesothelioma: Socioeconomic and Clinical Aspects;Current Cancer Therapy Reviews;2024-07-23

3. VP5 protein of oncolytic herpes simplex virus type 2 induces apoptosis in A549 cells through TP53I3 protein;Virology;2024-07

4. Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights;Open Respiratory Archives;2024-07

5. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas;Current Treatment Options in Oncology;2024-06-19